Skip to content

Inspiratory Muscle Training With Normocapnic Hyperpnea in Chronic Obstructive Pulmonary Disease (COPD)

Efficacy of Inspiratory Muscle Training by Means of Spirotiger® in COPD Patients.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01218295
Enrollment
20
Registered
2010-10-11
Start date
2009-05-31
Completion date
2011-07-31
Last updated
2010-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

COPD, inspiratory muscles training

Brief summary

Many studies suggest that inspiratory muscles training by means of normocapnic hyperpnea improves exercise tolerance in healthy subjects. No information is available about the use of this training in COPD patients even if other methods (such as threshold loading and resistive loading) have been shown to be effective in terms of Inspiratory Muscle Function, Health-Related Quality of Life and Exercise Tolerance. This study is designed to evaluate the effects of normocapnic hyperventilation by means of Spirotiger®, an instrument training the respiratory muscles, avoiding hypocapnia (using the methodology of isocapnic hyperpnoea)in COPD patients.

Interventions

DEVICESpirotiger®

training session :10 minutes twice a day X 4 weeks

Sponsors

Università degli Studi di Ferrara
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* COPD patients. All patients are at stable state, free from an exacerbation from at least 3 months.

Exclusion criteria

* COPD patients with a recent history of cardiovascular disease, neurologic disease and other diseases that would interfere with the training.

Design outcomes

Primary

MeasureTime frame
Exercise Capacity1 month

Countries

Italy

Contacts

Primary ContactAnnalisa Cogo, MD
cga@unife.it+390532210420
Backup ContactLuca Pomidori, PhD
pmdlcu@unife.it+390532455888

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026